Similarly, in the ccRCC subset, significant associations were detected between primary tumor TfR1 levels and a metastatic stage, lower BMI, lower hemoglobin and history of anemia and iron supplementation; and with greater differences than detected among all RCC patients (Table 2). The gene discussed is TFRC; the disease is anemia.